Bleakley Financial Group LLC Acquires 18,207 Shares of Colgate-Palmolive Company $CL

Bleakley Financial Group LLC boosted its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 86.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,162 shares of the company’s stock after acquiring an additional 18,207 shares during the period. Bleakley Financial Group LLC’s holdings in Colgate-Palmolive were worth $3,095,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. HighPoint Advisor Group LLC grew its holdings in Colgate-Palmolive by 0.7% during the 4th quarter. HighPoint Advisor Group LLC now owns 15,877 shares of the company’s stock worth $1,255,000 after acquiring an additional 109 shares in the last quarter. Sunpointe LLC grew its holdings in Colgate-Palmolive by 4.0% during the 4th quarter. Sunpointe LLC now owns 3,056 shares of the company’s stock worth $241,000 after acquiring an additional 117 shares in the last quarter. Capital Advisors Inc. OK grew its holdings in Colgate-Palmolive by 1.4% during the 4th quarter. Capital Advisors Inc. OK now owns 9,595 shares of the company’s stock worth $758,000 after acquiring an additional 129 shares in the last quarter. Stratos Wealth Advisors LLC grew its holdings in Colgate-Palmolive by 4.5% during the 3rd quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company’s stock worth $241,000 after acquiring an additional 130 shares in the last quarter. Finally, CYBER HORNET ETFs LLC grew its holdings in Colgate-Palmolive by 5.9% during the 4th quarter. CYBER HORNET ETFs LLC now owns 2,357 shares of the company’s stock worth $186,000 after acquiring an additional 131 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $91.24 on Thursday. The firm has a market capitalization of $73.01 billion, a P/E ratio of 35.50, a PEG ratio of 4.67 and a beta of 0.31. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33. The company has a 50 day moving average price of $86.20 and a 200 day moving average price of $85.51. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $99.33.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, May 1st. The company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The firm had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.22 billion. During the same period last year, the firm posted $0.91 EPS. Colgate-Palmolive’s revenue was up 8.4% on a year-over-year basis. Sell-side analysts expect that Colgate-Palmolive Company will post 3.82 EPS for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Monday, April 20th were given a dividend of $0.53 per share. The ex-dividend date of this dividend was Monday, April 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.3%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. Colgate-Palmolive’s payout ratio is 82.49%.

Wall Street Analysts Forecast Growth

CL has been the topic of a number of recent analyst reports. Royal Bank Of Canada restated an “outperform” rating and issued a $102.00 price target on shares of Colgate-Palmolive in a report on Monday, May 4th. Morgan Stanley restated an “overweight” rating on shares of Colgate-Palmolive in a report on Monday, May 4th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $99.00 price target on shares of Colgate-Palmolive in a report on Monday, May 4th. UBS Group raised their price target on shares of Colgate-Palmolive from $98.00 to $100.00 and gave the company a “buy” rating in a report on Monday, May 4th. Finally, Jefferies Financial Group raised their price target on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the company a “hold” rating in a report on Monday, February 2nd. Twelve analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $95.88.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.